A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine.
Clinical trial NCT00812981 · COMPLETED
Trial details
- NCT number
- NCT00812981
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-15
- Primary completion
- 2009-06-07
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.